Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pharmacokinetics of Oxaliplatin”

16 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 16 of 16 results

Testing effectiveness (Phase 2)Ended earlyNCT03488251
What this trial is testing

PK,PD,Safety and Tolerability of Multiple Dose Regimens of MT-3724 With Gemcitabine and Oxaliplatin for the Treatment of Patients With Relapsed/Refractory Diffuse Large B Cell Non-Hodgkin's Lymphoma

Who this might be right for
Non-hodgkin Lymphoma,B CellRefractory Diffuse Large B-Cell LymphomaRelapsed Diffuse Large B-Cell Lymphoma
Molecular Templates, Inc. 8
Early research (Phase 1)Study completedNCT00001835
What this trial is testing

Oxaliplatin in Cancer Patients With Impaired Kidney Function

Who this might be right for
Kidney DiseaseNeoplasmNeoplasm Metastasis
National Cancer Institute (NCI) 60
Testing effectiveness (Phase 2)Active Not RecruitingNCT03505320
What this trial is testing

Zolbetuximab (IMAB362) in Adults With Gastric Cancer

Who this might be right for
Pharmacokinetics of ZolbetuximabGastric CancerGastro-esophageal Junction (GEJ) Cancer+2 more
Astellas Pharma Global Development, Inc. 143
Early research (Phase 1)Study completedNCT00921661
What this trial is testing

Study of Intravenous Aflibercept in Combination With FOLFIRI in Japanese Patients With Metastatic Colorectal Cancer

Who this might be right for
Colorectal NeoplasmsNeoplasm Metastasis
Sanofi 16
Early research (Phase 1)Ended earlyNCT00300027
What this trial is testing

Study of BMS-582664 in Combination With Either FOLFIRI or FOLFOX for Gastrointestinal (GI) Malignancies

Who this might be right for
Gastrointestinal Neoplasms
Bristol-Myers Squibb 50
Large-scale testing (Phase 3)Not Yet RecruitingNCT07449780
What this trial is testing

AK104 (SC) in Combination With Oxaliplatin and Capecitabine (XELOX) Versus AK104 (IV) in Combination With XELOX in Participants With Unresectable Locally Advanced or Metastatic Gastric Adenocarcinoma or Gastroesophageal Junction Adenocarcinoma

Who this might be right for
Gastric / Gastroesophageal Junction Adenocarcinoma
Akeso 422
Testing effectiveness (Phase 2)Looking for participantsNCT05929885
What this trial is testing

Metronomic Capecitabine, Oxaliplatin and UGT1A1 Genotype-directed Irinotecan in Metastatic Pancreatic Cancer Patients

Who this might be right for
Metastatic Pancreatic Cancer
National Cancer Centre, Singapore 50
Testing effectiveness (Phase 2)WithdrawnNCT04282590
What this trial is testing

Investigate the Safety and Efficacy of TRK-750 for the Treatment of Patients With CIPN (Chopin Study)

Who this might be right for
Chemotherapy-induced Peripheral Neuropathy
Toray Industries, Inc
Large-scale testing (Phase 3)Looking for participantsNCT07409428
What this trial is testing

A Phase III Study of HMPL-760 Plus R-GemOx VS Placebo Plus R-GemOx in Relapsed/Refractory DLBCL

Who this might be right for
Relapsed/Refractory Diffuse Large B-Cell Lymphoma
Hutchmed 240
Early research (Phase 1)Study completedNCT00387387
What this trial is testing

Study On Pazopanib When Given With FOLFOX6 (Fluorouracil, Oxaliplatin, Leucovorin) Or CapeOx (Capecitabine, Oxaliplatin)

Who this might be right for
Neoplasms, Colorectal
GlaxoSmithKline 50
Testing effectiveness (Phase 2)Looking for participantsNCT03800693
What this trial is testing

2 Versus 6 Hour Oxaliplatin Infusions in Patients With Gastrointestinal Cancers

Who this might be right for
Malignant Digestive System Neoplasm
Emory University 60
Early research (Phase 1)Looking for participantsNCT06624085
What this trial is testing

A Study Evaluating the Safety and Efficacy of Glofitamab + Gemcitabine + Oxaliplatin in U.S. Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma

Who this might be right for
Lymphoma
Hoffmann-La Roche 50
Early research (Phase 1)UnknownNCT02211443
What this trial is testing

Safety, Tolerability and Pharmacokinetics of Recombinant Anti-epidermal Growth Factor Receptor(EGFR) Monoclonal Antibody in Patients With Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Sinocelltech Ltd. 21
Testing effectiveness (Phase 2)Study completedNCT02244632
What this trial is testing

Modufolin (Arfolitixorin) in Combination With 5-Fluorouracil Alone or Together With Oxaliplatin or Irinotecan in Colorectal Cancer

Who this might be right for
Colorectal Neoplasm
Isofol Medical AB 105
Testing effectiveness (Phase 2)Study completedNCT01579357
What this trial is testing

Pharmacokinetics and Metabolic Activation of Capecitabine

Who this might be right for
Metastatic Colorectal Cancer
Arbeitsgemeinschaft medikamentoese Tumortherapie 24
Early research (Phase 1)Study completedNCT00006062
What this trial is testing

Oxaliplatin to Treat Advanced Cancers With Liver Dysfunction

Who this might be right for
Liver Disease
National Cancer Institute (NCI) 60